ST. PETERSBURG, FL, Jan. 14, 2015 (GLOBE NEWSWIRE) -- FutureWorld Corp. (FWDG), a leading provider of advanced technologies and solutions to the global cannabis industry, announces today the launch of EssenceTM CBD, a high concentration, all-natural, Cannabidiol-rich Hemp Oil through its subsidiary, NutraCann Labs, Inc.
Initial retail sales will be through 1ml cartridges, 10ml & 50ml bottles and starter kits with the sleek URVape vaporizer pen. Bulk rate kilograms will also be available at the wholesale level. The product is available immediately online at www.cbdessence.com and www.urvape.com . "We anticipate rolling out a full-line of products relating to CBD in the very near future. I am excited to be teaming up with our sister company URVape, Inc. to provide high quality, CBD rich, vapable hemp oil through "SafeVape" vaporizers online", said CEO of NutraCann Labs, Inc., Don Ballou.
The Company has spent the last few months ensuring all source material was free of heavy metals or other toxins. The results of the company's efforts have made available an absolutely pristine quality whole-food supplement that represents "the Essence" of the plant says Don Ballou. There are some hundreds of phytonutrients that exist in hemp plants and it is absolutely essential to capture the full spectrum of these valuable & beneficial molecules. Using Super Critical Extraction Technology (CO2) makes it possible to extract the essential phytonutrients without the use of excessive heat or other undesirable solvents.
NutraCann's Real Pharmaceutical Grade CBD-rich hemp oil comes from the whole hemp plant and does not contain any synthetics nor is it an isolate.
FutureWorld is committed to being a leader in the space for product safety and quality control. With so many snake oils, imitations and down-right "zero-potency" CBD oil being sold on the market today at obscene prices, we have made it our cause to bring much needed legitimacy and integrity back to the market.
"Since our announcement on December 10, 2014, we have received numerous phone calls, emails, and other inquiries regarding the sale of our CBD products. While we have already begun to sell some to wholesale suppliers, we have also created our own brand to make sure that we can take advantage of the burgeoning retail market," commented CEO Sam Talari. "We are determined to create a brand with CBD EssenceTM that will instill customer trust and loyalty well into the future. CBD EssenceTM is only the first in many planned offerings of CBD-infused pharmaceuticals and nutraceutical under our umbrella."
Tetrahydrocannabinol (THC), the psychoactive phytocannabinoid (planet-based) found in cannabis, has rapidly become eclipsed by the non-psychoactive phytocannabinoid, Cannabidiol (CBD), and derived mainly from Hemp, which is considered to have wider-ranging medical applications. CBD has even received orphan drug status in the U.S., fast-tracking the substance for use in treating a severe, rare form of crippling epilepsy known as Dravet Syndrome. A highly purified CBD extract developed by UK-based GW Pharmaceuticals, has now gone into landmark clinical trialing for epilepsy at the biggest children's hospital in the country with initial trials that began in April of 2014 which has already shown encouraging results in kids with treatment-resistant epilepsy. There is increasing major demand across the board for hemp based CBD oil, due to a compelling combination of study data, mounting empirical evidence, and positive feedback from parents whose children suffer from debilitating seizures. http://finance.yahoo.com/news/futureworld-fwdg-unveils-essence-real-130900654.html;_ylt=A0LEV1hhbbZUWFsAmgZXNyoA
News 
Market Data 
Discover 
AI
